Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108024148 | 10802414 | 8 | F | 20160923 | 20150217 | 20160928 | EXP | US-PFIZER INC-2015057777 | PFIZER | 82.00 | YR | F | Y | 71.00000 | KG | 20160928 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108024148 | 10802414 | 1 | PS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY | 20753 | 25 | MG | COATED TABLET | QD | ||||||
| 108024148 | 10802414 | 2 | SS | AROMASIN | EXEMESTANE | 1 | 20753 | COATED TABLET | |||||||||||
| 108024148 | 10802414 | 3 | SS | AROMASIN | EXEMESTANE | 1 | 20753 | COATED TABLET | |||||||||||
| 108024148 | 10802414 | 4 | SS | AROMASIN | EXEMESTANE | 1 | 20753 | COATED TABLET | |||||||||||
| 108024148 | 10802414 | 5 | SS | TYKERB | LAPATINIB DITOSYLATE | 1 | Oral | 1250 MG (5 TABLETS OF 250 MG), 1X/DAY | WZP4807 | 0 | 1250 | MG | TABLET | QD | |||||
| 108024148 | 10802414 | 6 | SS | TYKERB | LAPATINIB DITOSYLATE | 1 | 1250 MG, 1X/DAY | 4ZP4807 | 0 | 1250 | MG | TABLET | QD | ||||||
| 108024148 | 10802414 | 7 | SS | TYKERB | LAPATINIB DITOSYLATE | 1 | UNK | 109975432024 | 0 | TABLET | |||||||||
| 108024148 | 10802414 | 8 | SS | TYKERB | LAPATINIB DITOSYLATE | 1 | UNK | A100652 | 0 | TABLET | |||||||||
| 108024148 | 10802414 | 9 | SS | TYKERB | LAPATINIB DITOSYLATE | 1 | UNK | 5ZP7784 | 0 | TABLET | |||||||||
| 108024148 | 10802414 | 10 | SS | TYKERB | LAPATINIB DITOSYLATE | 1 | UNK | 5BP7784 | 0 | TABLET | |||||||||
| 108024148 | 10802414 | 11 | SS | TYKERB | LAPATINIB DITOSYLATE | 1 | UNK | 0 | TABLET | ||||||||||
| 108024148 | 10802414 | 12 | C | VANCOMYCIN | VANCOMYCIN | 1 | UNK, 2X/DAY (TWICE A DAY FOR 90 MINUTES OVER A SIX WEEK TIME PERIOD) | 0 | BID | ||||||||||
| 108024148 | 10802414 | 13 | C | AMITRIPTYLINE HCL | AMITRIPTYLINE | 1 | 25 MG, UNK | 0 | 25 | MG | TABLET | ||||||||
| 108024148 | 10802414 | 14 | C | ATENOLOL. | ATENOLOL | 1 | 25 MG, UNK | 0 | 25 | MG | TABLET | ||||||||
| 108024148 | 10802414 | 15 | C | CEPHALEXINE | CEPHALEXIN | 1 | 500 MG, UNK | 0 | 500 | MG | CAPSULE | ||||||||
| 108024148 | 10802414 | 16 | C | DOXYCYCLINE HYCLATE. | DOXYCYCLINE HYCLATE | 1 | 100 MG, UNK | 0 | 100 | MG | CAPSULE | ||||||||
| 108024148 | 10802414 | 17 | C | FENTANYL. | FENTANYL | 1 | 25 ?G, UNK | 0 | 25 | UG | |||||||||
| 108024148 | 10802414 | 18 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | 100 MG, UNK | 0 | 100 | MG | TABLET | ||||||||
| 108024148 | 10802414 | 19 | C | METFORMIN HCL | METFORMIN HYDROCHLORIDE | 1 | 500 MG, UNK | 0 | 500 | MG | TABLET | ||||||||
| 108024148 | 10802414 | 20 | C | MUPIROCIN. | MUPIROCIN | 1 | UNK | 0 | OINTMENT | ||||||||||
| 108024148 | 10802414 | 21 | C | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | 5 MG, UNK | 0 | 5 | MG | TABLET | ||||||||
| 108024148 | 10802414 | 22 | C | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK (HYDROCODONE- ACETAMINOPHEN 5-325) | 0 | |||||||||||
| 108024148 | 10802414 | 23 | C | FASLODEX | FULVESTRANT | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 108024148 | 10802414 | 1 | Breast cancer stage IV |
| 108024148 | 10802414 | 2 | Invasive breast carcinoma |
| 108024148 | 10802414 | 3 | Breast cancer |
| 108024148 | 10802414 | 4 | Breast cancer metastatic |
| 108024148 | 10802414 | 5 | Breast cancer stage IV |
| 108024148 | 10802414 | 6 | Invasive breast carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 108024148 | 10802414 | OT |
| 108024148 | 10802414 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 108024148 | 10802414 | Bone disorder | |
| 108024148 | 10802414 | Diabetic foot infection | |
| 108024148 | 10802414 | Limb injury | |
| 108024148 | 10802414 | Osteomyelitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 108024148 | 10802414 | 1 | 201209 | 0 | ||
| 108024148 | 10802414 | 5 | 201209 | 0 | ||
| 108024148 | 10802414 | 6 | 201209 | 0 |